Top UFC women's flyweight contender Manon Fiorot has been suspended three months for a violation of the promotion's anti-doping policy.
Fiorot tested positive for low levels of ostarine through an in-competition urine sample collected around her Sept. 12 bout vs. Alexa Grasso, UFC anti-doping program CSAD announced Thursday. A second sample collected Oct. 16, prior to Fiorot being notified of the violation, returned negative results.
Fiorot, 36, provided CSAD with a list of new supplements she had begun taking at the recommendation of a nutritionist. That nutritionist had saved samples of each supplement and submitted them to CSAD, which forwarded them to Sports Medicine and Research Testing Laboratory (SMRTL) for evaluation.
SMRTL detected low
levels of ostarine contamination in the supplements. CSAD determined the use was due to inadvertent exposure, and added that the level in Fiorot's system did not give her any competitive advantage.
Fiorot will be eligible to return to competition on Jan. 19, 2027, three months after she was notified of the failure.
The Arizona State Boxing and Mixed Martial Arts Commission, which oversaw Fiorot's bout vs. Grasso at Diamond Desert Arena in Glendale, Ariz., has informed the UFC that it will not impose further disciplinary action.
Fiorot has no prior history of failed drug tests and according to CSAD was fully cooperative throughout the process.
A former UFC title challenger, Fiorot lost the bout to Grasso via unanimous decision, dropping her to 1-2 in her most recent three. She does not currently have a return fight on the books.
This article originally appeared on MMA Junkie: UFC suspends Manon Fiorot three months for anti-doping violation













